CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for KDA Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

KDA Group Inc
Bureau 300, 1351, rue Notre-Dame Est
Phone: (514) 715-0376p:514 715-0376 THETFORD MINES, QC  G6G 0G5  Canada Ticker: KDAKDA
Business Summary
KDA Group Inc. is a Canada-based company focused on the development and marketing of its technological products and specialized software solutions for the healthcare market. The Company operates through Pharmaceutical Technology segment. It is focused on developing its technological products across four different platforms: KRX Medical, KRX Dental, KRX Cannabinoid and Adherize (ADRX). The KRX Dental is an electronic prescription platform assisting dentists in their practice. The KRX Medical is an electronic prescription platform assisting physicians in their practice. The KRX Cannabinoid is an electronic prescription platform assisting physicians in their practice when prescribing medical cannabis. The ADRX platform offers content allowing healthcare professionals (doctors and pharmacists) to virtually present various information. The platform includes various modules: Intelligent dialogue system, online questionnaire, pharmacist dashboard, developed algorithms, and a patient portal.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
4/30/20247/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer MarcLemieux 9/14/2021 1/8/2015
Chief Financial Officer, Director Michael W.Kinley 9/1/2023 9/1/2023
Director IsabelleBegin 6/27/2023 1/8/2015
Independent Director PatrickFernet 1/8/2015 1/8/2015

Business Names
Business Name
9277396 Canada Inc.
9287396 Canada Inc.
9321-5317 Quebec Inc.
10 additional Business Names available in full report.

General Information
Outstanding Shares: 175,699,280 (As of 10/31/2024)
Stock Exchange: CVE
Fax Number: (418) 755-0822


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024